Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-World Characterization of the Portuguese Population Living with HIV who Initiated Raltegravir Based-Regimens: The REALITY Study.
Serrão R, Mansinho K, Maltez F, Marques N, Carvalho A, Pazos R, Zagalo A, Mendez J, Neves I, Oliveira J, Pacheco P, Correia de Abreu R, Miranda AC, Camacho P, Paixão L, Almeida J. Serrão R, et al. Among authors: maltez f. Acta Med Port. 2022 Jul 1;35(7-8):558-565. doi: 10.20344/amp.16785. Epub 2022 Mar 25. Acta Med Port. 2022. PMID: 35333155 Free article.
HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.
Cavaco-Silva J, Abecasis A, Miranda AC, Poças J, Narciso J, Águas MJ, Maltez F, Almeida I, Germano I, Diniz A, Gonçalves Mde F, Gomes P, Cunha C, Camacho RJ; Portuguese HIV-2 Resistance Study Group. Cavaco-Silva J, et al. Among authors: maltez f. PLoS One. 2014 Mar 28;9(3):e92747. doi: 10.1371/journal.pone.0092747. eCollection 2014. PLoS One. 2014. PMID: 24681625 Free PMC article.
Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: The AGING POSITIVE study.
Serrão R, Piñero C, Velez J, Coutinho D, Maltez F, Lino S, Sarmento E Castro R, Tavares AP, Pacheco P, Lopes MJ, Mansinho K, Miranda AC, Neves I, Correia de Abreu R, Almeida J, Pássaro L. Serrão R, et al. Among authors: maltez f. Int J Infect Dis. 2019 Feb;79:94-100. doi: 10.1016/j.ijid.2018.10.011. Epub 2018 Oct 25. Int J Infect Dis. 2019. PMID: 30529370 Free article.
Severe Acute Hepatitis E in a Woman with an Autoimmune Background.
Nascimento MS, Almeida-Santos M, Fernandes M, Maltez F, Lino S, Curran MD, Mesquita JR. Nascimento MS, et al. Among authors: maltez f. Acta Med Port. 2020 Jun 1;33(6):425-428. doi: 10.20344/amp.10429. Epub 2020 May 31. Acta Med Port. 2020. PMID: 32504518 Free article.
The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study.
Mocroft A, Miro JM, Wandeler G, Llibre JM, Boyd A, van Bremen K, Beniowski M, Mikhalik J, Cavassini M, Maltez F, Duvivier C, Uberti Foppa C, Knysz B, Bakowska E, Kuzovatova E, Domingo P, Zagalo A, Viard JP, Degen O, Milinkovic A, Benfield T, Peters L; EuroSIDA study group. Mocroft A, et al. Among authors: maltez f. HIV Med. 2022 Jul;23(6):585-598. doi: 10.1111/hiv.13210. Epub 2021 Dec 9. HIV Med. 2022. PMID: 34889022
HIV-1-Transmitted Drug Resistance and Transmission Clusters in Newly Diagnosed Patients in Portugal Between 2014 and 2019.
Pingarilho M, Pimentel V, Miranda MNS, Silva AR, Diniz A, Ascenção BB, Piñeiro C, Koch C, Rodrigues C, Caldas C, Morais C, Faria D, da Silva EG, Teófilo E, Monteiro F, Roxo F, Maltez F, Rodrigues F, Gaião G, Ramos H, Costa I, Germano I, Simões J, Oliveira J, Ferreira J, Poças J, da Cunha JS, Soares J, Henriques J, Mansinho K, Pedro L, Aleixo MJ, Gonçalves MJ, Manata MJ, Mouro M, Serrado M, Caixeiro M, Marques N, Costa O, Pacheco P, Proença P, Rodrigues P, Pinho R, Tavares R, de Abreu RC, Côrte-Real R, Serrão R, Castro RSE, Nunes S, Faria T, Baptista T, Martins MRO, Gomes P, Mendão L, Simões D, Abecasis A. Pingarilho M, et al. Among authors: maltez f. Front Microbiol. 2022 Apr 25;13:823208. doi: 10.3389/fmicb.2022.823208. eCollection 2022. Front Microbiol. 2022. PMID: 35558119 Free PMC article.
Safety and Efficacy of Triple Therapy With Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors in Treatment-Naive Human Immunodeficiency Virus Type 2 Patients: Results From a 48-Week Phase 2 Study.
Pacheco P, Marques N, Rodrigues P, Mansinho K, Maltez F, Janeiro N, Franco C, Trigo D, Batista J, Duque L, Lopes MJ, Aleixo MJ, Silva AR, Tavares R, Alves J, Peres S, Póvoas D, Lino S, Gomes P, Araújo V, Lopes C. Pacheco P, et al. Among authors: maltez f. Clin Infect Dis. 2023 Sep 11;77(5):740-748. doi: 10.1093/cid/ciad339. Clin Infect Dis. 2023. PMID: 37288954 Clinical Trial.
163 results